Medicolegal Risks and the COVID-19 Vaccine Rollout

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Dr Linda Calabresi

 

This week’s experts:
Dr Penny Browne, GP; Senior Staff Specialist in General Practice, Hornsby Hospital, Sydney; Chief Medical Officer, Avant
Ms Georgie Maysom, Lawyer; Head of Research, Education and Advocacy, Avant

Drawn from the lecture interview with Dr Penny Browne and Ms Georgie Maysom on the Healthed Podcast, ‘Medicolegal Risks and the COVID-19 Vaccine Rollout’

– Ensure people presenting for the vaccine are eligible. This is more of a challenge when people who don’t usually come to your practice present for vaccination. Can ask for a health summary from usual doctor, or get them to complete a medical history questionnaire. Easiest solution is to get patient to complete an ‘eligibility declaration’ – downloadable from the Department of Health website.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Daryl Efron

A/Prof Daryl Efron

Autism Spectrum Disorder in Children

Dr Sonia Davison

Dr Sonia Davison

Early Menopause

Scientia Prof Henry Brodaty AO

Scientia Prof Henry Brodaty AO

Donanemab – A GP Guide to Anti-Amyloid Therapies

Prof Andrew Sindone

Prof Andrew Sindone

LDL and Cardiovascular Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Test your knowledge

Recent articles

Latest GP poll

When do you plan to retire or leave general practice?

Within the next 12 months

0%

Within the next 3 years

0%

Within the next 5 years

0%

Within the next 10 years

0%

More than 10 years

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease